{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T20:08:07Z","timestamp":1788984487875,"version":"build-2803163510"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2010,6,11]],"date-time":"2010-06-11T00:00:00Z","timestamp":1276214400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2010,11]]},"DOI":"10.1007\/s00259-010-1496-z","type":"journal-article","created":{"date-parts":[[2010,6,10]],"date-time":"2010-06-10T17:16:02Z","timestamp":1276190162000},"page":"2188-2193","source":"Crossref","is-referenced-by-count":84,"title":["PET with 18F-labelled choline-based tracers for tumour imaging: a review of the literature"],"prefix":"10.1007","volume":"37","author":[{"given":"Koen","family":"Mertens","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Slaets","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bieke","family":"Lambert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marjan","family":"Acou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filip","family":"De Vos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingeborg","family":"Goethals","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,6,11]]},"reference":[{"key":"1496_CR1","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1053\/j.semnuclmed.2007.08.004","volume":"37","author":"S Vallabhajosula","year":"2007","unstructured":"Vallabhajosula S. (18)F-Labeled positron emission tomographic radiopharmaceuticals in oncology: an overview of radiochemistry and mechanisms of tumor localization. Semin Nucl Med 2007;37:400\u201319.","journal-title":"Semin Nucl Med"},{"key":"1496_CR2","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1097\/01.mco.0000232894.28674.30","volume":"9","author":"JV Swinnen","year":"2006","unstructured":"Swinnen JV, Brusselmans K, Verhoeven G. Increased lipogenesis in cancer cells: new players, novel targets. Curr Opin Clin Nutr Metab Care 2006;9:358\u201365.","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"1496_CR3","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1002\/(SICI)1099-1492(199911)12:7<413::AID-NBM587>3.0.CO;2-U","volume":"12","author":"F Podo","year":"1999","unstructured":"Podo F. Tumour phospholipid metabolism. NMR Biomed 1999;12:413\u201339.","journal-title":"NMR Biomed"},{"key":"1496_CR4","first-page":"3599","volume":"61","author":"E Ackerstaff","year":"2001","unstructured":"Ackerstaff E, Pflug BR, Nelson JB, Bhujwalla ZM. Detection of increased choline compounds with proton nuclear magnetic resonance spectroscopy subsequent to malignant transformation of human prostatic epithelial cells. Cancer Res 2001;61:3599\u2013603.","journal-title":"Cancer Res"},{"key":"1496_CR5","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1002\/mrm.10614","volume":"50","author":"MG Swanson","year":"2003","unstructured":"Swanson MG, Vigneron DB, Tabatabai ZL, Males RG, Schmitt L, Carroll PR, et al. Proton HR-MAS spectroscopy and quantitative pathologic analysis of MRI\/3D-MRSI-targeted postsurgical prostate tissues. Magn Reson Med 2003;50:944\u201354.","journal-title":"Magn Reson Med"},{"key":"1496_CR6","first-page":"4630","volume":"56","author":"KK Bhakoo","year":"1996","unstructured":"Bhakoo KK, Williams SR, Florian CL, Land H, Noble MD. Immortalization and transformation are associated with specific alterations in choline metabolism. Cancer Res 1996;56:4630\u20135.","journal-title":"Cancer Res"},{"key":"1496_CR7","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1111\/j.1349-7006.1999.tb00764.x","volume":"90","author":"K Nakagami","year":"1999","unstructured":"Nakagami K, Uchida T, Ohwada S, Koibuchi Y, Suda Y, Sekine T, et al. Increased choline kinase activity and elevated phosphocholine levels in human colon cancer. Jpn J Cancer Res 1999;90:419\u201324.","journal-title":"Jpn J Cancer Res"},{"key":"1496_CR8","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/S0006-291X(02)00920-8","volume":"296","author":"A Ramirez de Molina","year":"2002","unstructured":"Ramirez de Molina A, Rodriguez-Gonzalez A, Gutierrez R, Martinez-Pineiro L, Sanchez J, Bonilla F, et al. Overexpression of choline kinase is a frequent feature in human tumor-derived cell lines and in lung, prostate, and colorectal human cancers. Biochem Biophys Res Commun 2002;296:580\u20133.","journal-title":"Biochem Biophys Res Commun"},{"key":"1496_CR9","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/PL00006658","volume":"27","author":"A Roivainen","year":"2000","unstructured":"Roivainen A, Forsback S, Gronroos T, Lehikoinen P, Kahkonen M, Sutinen E, et al. Blood metabolism of [methyl-11C]choline; implications for in vivo imaging with positron emission tomography. Eur J Nucl Med 2000;27:25\u201332.","journal-title":"Eur J Nucl Med"},{"key":"1496_CR10","first-page":"110","volume":"61","author":"TR DeGrado","year":"2001","unstructured":"DeGrado TR, Coleman RE, Wang S, Baldwin SW, Orr MD, Robertson CN, et al. Synthesis and evaluation of 18F-labeled choline as an oncologic tracer for positron emission tomography: initial findings in prostate cancer. Cancer Res 2001;61:110\u20137.","journal-title":"Cancer Res"},{"key":"1496_CR11","first-page":"187","volume":"43","author":"T Hara","year":"2002","unstructured":"Hara T, Kosaka N, Kishi H. Development of (18)F-fluoroethylcholine for cancer imaging with PET: synthesis, biochemistry, and prostate cancer imaging. J Nucl Med 2002;43:187\u201399.","journal-title":"J Nucl Med"},{"key":"1496_CR12","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1007\/s00259-008-0736-y","volume":"35","author":"A Bansal","year":"2008","unstructured":"Bansal A, Shuyan W, Hara T, Harris RA, Degrado TR. Biodisposition and metabolism of [(18)F]fluorocholine in 9L glioma cells and 9L glioma-bearing fisher rats. Eur J Nucl Med Mol Imaging 2008;35:1192\u2013203.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1496_CR13","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1053\/j.semnuclmed.2007.07.003","volume":"37","author":"SA Kwee","year":"2007","unstructured":"Kwee SA, DeGrado TR, Talbot JN, Gutman F, Coel MN. Cancer imaging with fluorine-18-labeled choline derivatives. Semin Nucl Med 2007;37:420\u20138.","journal-title":"Semin Nucl Med"},{"key":"1496_CR14","first-page":"1815","volume":"42","author":"T Hara","year":"2001","unstructured":"Hara T. 18F-fluorocholine: a new oncologic PET tracer. J Nucl Med 2001;42:1815\u20137.","journal-title":"J Nucl Med"},{"key":"1496_CR15","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/S0969-8043(02)00123-9","volume":"57","author":"R Iwata","year":"2002","unstructured":"Iwata R, Pascali C, Bogni A, Furumoto S, Terasaki K, Yanai K. [18F]Fluoromethyl triflate, a novel and reactive [18F]fluoromethylating agent: preparation and application to the on-column preparation of [18F]fluorocholine. Appl Radiat Isot 2002;57:347\u201352.","journal-title":"Appl Radiat Isot"},{"key":"1496_CR16","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.nucmedbio.2007.11.008","volume":"35","author":"D Kryza","year":"2008","unstructured":"Kryza D, Tadino V, Filannino MA, Villeret G, Lemoucheux L. Fully automated [18F]fluorocholine synthesis in the TracerLab MX FDG Coincidence synthesizer. Nucl Med Biol 2008;35:255\u201360.","journal-title":"Nucl Med Biol"},{"key":"1496_CR17","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1159\/000112946","volume":"72","author":"N Takahashi","year":"2007","unstructured":"Takahashi N, Inoue T, Lee J, Yamaguchi T, Shizukuishi K. The roles of PET and PET\/CT in the diagnosis and management of prostate cancer. Oncology 2007;72:226\u201333.","journal-title":"Oncology"},{"key":"1496_CR18","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1159\/000019746","volume":"34","author":"HP Beerlage","year":"1998","unstructured":"Beerlage HP, de Reijke TM, de la Rosette JJ. Considerations regarding prostate biopsies. Eur Urol 1998;34:303\u201312.","journal-title":"Eur Urol"},{"key":"1496_CR19","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1159\/000049787","volume":"40","author":"JP Sedelaar","year":"2001","unstructured":"Sedelaar JP, Vijverberg PL, De Reijke TM, de la Rosette JJ, Kil PJ, Braeckman JG, et al. Transrectal ultrasound in the diagnosis of prostate cancer: state of the art and perspectives. Eur Urol 2001;40:275\u201384.","journal-title":"Eur Urol"},{"key":"1496_CR20","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0360-3016(00)00637-4","volume":"48","author":"J Crook","year":"2000","unstructured":"Crook J, Malone S, Perry G, Bahadur Y, Robertson S, Abdolell M. Postradiotherapy prostate biopsies: what do they really mean? Results for 498 patients. Int J Radiat Oncol Biol Phys 2000;48:355\u201367.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1496_CR21","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1097\/MOU.0b013e3282f13ac3","volume":"18","author":"D Pucar","year":"2008","unstructured":"Pucar D, Sella T, Schoder H. The role of imaging in the detection of prostate cancer local recurrence after radiation therapy and surgery. Curr Opin Urol 2008;18:87\u201397.","journal-title":"Curr Opin Urol"},{"key":"1496_CR22","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1148\/radiol.2431030580","volume":"243","author":"H Hricak","year":"2007","unstructured":"Hricak H, Choyke PL, Eberhardt SC, Leibel SA, Scardino PT. Imaging prostate cancer: a multidisciplinary perspective. Radiology 2007;243:28\u201353.","journal-title":"Radiology"},{"key":"1496_CR23","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1148\/radiol.2381052345","volume":"238","author":"E Sala","year":"2006","unstructured":"Sala E, Eberhardt SC, Akin O, Moskowitz CS, Onyebuchi CN, Kuroiwa K, et al. Endorectal MR imaging before salvage prostatectomy: tumor localization and staging. Radiology 2006;238:176\u201383.","journal-title":"Radiology"},{"key":"1496_CR24","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1177\/107327480401100602","volume":"11","author":"MR Hersh","year":"2004","unstructured":"Hersh MR, Knapp EL, Choi J. Newer imaging modalities to assess tumor in the prostate. Cancer Control 2004;11:353\u20137.","journal-title":"Cancer Control"},{"key":"1496_CR25","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1148\/radiol.2382041905","volume":"238","author":"L Wang","year":"2006","unstructured":"Wang L, Hricak H, Kattan MW, Chen HN, Scardino PT, Kuroiwa K. Prediction of organ-confined prostate cancer: incremental value of MR imaging and MR spectroscopic imaging to staging nomograms. Radiology 2006;238:597\u2013603.","journal-title":"Radiology"},{"key":"1496_CR26","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1148\/radiology.213.2.r99nv23473","volume":"213","author":"J Scheidler","year":"1999","unstructured":"Scheidler J, Hricak H, Vigneron DB, Yu KK, Sokolov DL, Huang LR, et al. Prostate cancer: localization with three-dimensional proton MR spectroscopic imaging \u2013 clinicopathologic study. Radiology 1999;213:473\u201380.","journal-title":"Radiology"},{"key":"1496_CR27","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1080\/02841850802004983","volume":"49","author":"M Chen","year":"2008","unstructured":"Chen M, Dang HD, Wang JY, Zhou C, Li SY, Wang WC, et al. Prostate cancer detection: comparison of T2-weighted imaging, diffusion-weighted imaging, proton magnetic resonance spectroscopic imaging, and the three techniques combined. Acta Radiol 2008;49:602\u201310.","journal-title":"Acta Radiol"},{"key":"1496_CR28","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1148\/radiol.2352040494","volume":"235","author":"DT Schmid","year":"2005","unstructured":"Schmid DT, John H, Zweifel R, Cservenyak T, Westera G, Goerres GW, et al. Fluorocholine PET\/CT in patients with prostate cancer: initial experience. Radiology 2005;235:623\u20138.","journal-title":"Radiology"},{"key":"1496_CR29","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1097\/01.ju.0000142099.80156.85","volume":"173","author":"SA Kwee","year":"2005","unstructured":"Kwee SA, Coel MN, Lim J, Ko JP. Prostate cancer localization with 18fluorine fluorocholine positron emission tomography. J Urol 2005;173:252\u20135.","journal-title":"J Urol"},{"key":"1496_CR30","first-page":"262","volume":"47","author":"SA Kwee","year":"2006","unstructured":"Kwee SA, Wei H, Sesterhenn I, Yun D, Coel MN. Localization of primary prostate cancer with dual-phase 18F-fluorocholine PET. J Nucl Med 2006;47:262\u20139.","journal-title":"J Nucl Med"},{"key":"1496_CR31","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1007\/s00259-007-0686-9","volume":"35","author":"I Igerc","year":"2008","unstructured":"Igerc I, Kohlfurst S, Gallowitsch HJ, Matschnig S, Kresnik E, Gomez-Segovia I, et al. The value of 18F-choline PET\/CT in patients with elevated PSA-level and negative prostate needle biopsy for localisation of prostate cancer. Eur J Nucl Med Mol Imaging 2008;35:976\u201383.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1496_CR32","first-page":"12","volume":"7","author":"SA Kwee","year":"2008","unstructured":"Kwee SA, Thibault GP, Stack RS, Coel MN, Furusato B, Sesterhenn IA. Use of step-section histopathology to evaluate 18F-fluorocholine PET sextant localization of prostate cancer. Mol Imaging 2008;7:12\u201320.","journal-title":"Mol Imaging"},{"key":"1496_CR33","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/S0090-4295(98)00518-4","volume":"53","author":"R Tiguert","year":"1999","unstructured":"Tiguert R, Gheiler EL, Tefilli MV, Oskanian P, Banerjee M, Grignon DJ, et al. Lymph node size does not correlate with the presence of prostate cancer metastasis. Urology 1999;53:367\u201371.","journal-title":"Urology"},{"key":"1496_CR34","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1016\/j.juro.2006.07.037","volume":"176","author":"A H\u00e4cker","year":"2006","unstructured":"H\u00e4cker A, Jeschke S, Leeb K, Prammer K, Ziegerhofer J, Sega W, et al. Detection of pelvic lymph node metastases in patients with clinically localized prostate cancer: comparison of [18F]fluorocholine positron emission tomography-computerized tomography and laparoscopic radioisotope guided sentinel lymph node dissection. J Urol 2006;176:2014\u20138.","journal-title":"J Urol"},{"key":"1496_CR35","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/s00259-007-0552-9","volume":"35","author":"DB Husarik","year":"2008","unstructured":"Husarik DB, Miralbell R, Dubs M, John H, Giger OT, Gelet A, et al. Evaluation of [(18)F]-choline PET\/CT for staging and restaging of prostate cancer. Eur J Nucl Med Mol Imaging 2008;35:253\u201363.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1496_CR36","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1053\/j.semnuclmed.2005.09.002","volume":"36","author":"W Langsteger","year":"2006","unstructured":"Langsteger W, Heinisch M, Fogelman I. The role of fluorodeoxyglucose, 18F-dihydroxyphenylalanine, 18F-choline, and 18F-fluoride in bone imaging with emphasis on prostate and breast. Semin Nucl Med 2006;36:73\u201392.","journal-title":"Semin Nucl Med"},{"key":"1496_CR37","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s11307-005-0023-2","volume":"8","author":"M Heinisch","year":"2006","unstructured":"Heinisch M, Dirisamer A, Loidl W, Stoiber F, Gruy B, Haim S, et al. Positron emission tomography\/computed tomography with F-18-fluorocholine for restaging of prostate cancer patients: meaningful at PSA <5\u00a0ng\/ml? Mol Imaging Biol 2006;8:43\u20138.","journal-title":"Mol Imaging Biol"},{"key":"1496_CR38","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1007\/s00259-006-0150-2","volume":"33","author":"M Cimitan","year":"2006","unstructured":"Cimitan M, Bortolus R, Morassut S, Canzonieri V, Garbeglio A, Baresic T, et al. [18F]Fluorocholine PET\/CT imaging for the detection of recurrent prostate cancer at PSA relapse: experience in 100 consecutive patients. Eur J Nucl Med Mol Imaging 2006;33:1387\u201398.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1496_CR39","doi-asserted-by":"crossref","first-page":"650","DOI":"10.6004\/jnccn.2007.0056","volume":"5","author":"J Mohler","year":"2007","unstructured":"Mohler J, Babaian RJ, Bahnson RR, Boston B, D\u2019Amico A, Eastham JA, et al. Prostate cancer. Clinical practice guidelines in oncology. J Natl Compr Canc Netw 2007;5:650\u201383.","journal-title":"J Natl Compr Canc Netw"},{"key":"1496_CR40","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1007\/s11547-008-0263-8","volume":"113","author":"E Pelosi","year":"2008","unstructured":"Pelosi E, Arena V, Skanjeti A, Pirro V, Douroukas A, Pupi A, et al. Role of whole-body 18F-choline PET\/CT in disease detection in patients with biochemical relapse after radical treatment for prostate cancer. Radiol Med 2008;113:895\u2013904.","journal-title":"Radiol Med"},{"key":"1496_CR41","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1111\/j.1464-410X.2007.06772.x","volume":"99","author":"H Vees","year":"2007","unstructured":"Vees H, Buchegger F, Albrecht S, Khan H, Husarik D, Zaidi H, et al. 18F-Choline and\/or 11C-acetate positron emission tomography: detection of residual or progressive subclinical disease at very low prostate-specific antigen values (<1\u00a0ng\/mL) after radical prostatectomy. BJU Int 2007;99:1415\u201320.","journal-title":"BJU Int"},{"key":"1496_CR42","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S1536-1632(02)00015-X","volume":"4","author":"T Hara","year":"2002","unstructured":"Hara T. 11C-Choline and 2-deoxy-2-[18F]fluoro-D-glucose in tumor imaging with positron emission tomography. Mol Imaging Biol 2002;4:267\u201373.","journal-title":"Mol Imaging Biol"},{"key":"1496_CR43","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1111\/j.1552-6569.2004.tb00253.x","volume":"14","author":"SA Kwee","year":"2004","unstructured":"Kwee SA, Coel MN, Lim J, Ko JP. Combined use of F-18 fluorocholine positron emission tomography and magnetic resonance spectroscopy for brain tumor evaluation. J Neuroimaging 2004;14:285\u20139.","journal-title":"J Neuroimaging"},{"key":"1496_CR44","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1148\/radiol.2442060898","volume":"244","author":"SA Kwee","year":"2007","unstructured":"Kwee SA, Ko JP, Jiang CS, Watters MR, Coel MN. Solitary brain lesions enhancing at MR imaging: evaluation with fluorine 18 fluorocholine PET. Radiology 2007;244:557\u201365.","journal-title":"Radiology"},{"key":"1496_CR45","first-page":"1931","volume":"45","author":"N Spaeth","year":"2004","unstructured":"Spaeth N, Wyss MT, Weber B, Scheidegger S, Lutz A, Verwey J, et al. Uptake of 18F-fluorocholine, 18F-fluoroethyl-L-tyrosine, and 18F-FDG in acute cerebral radiation injury in the rat: implications for separation of radiation necrosis from tumor recurrence. J Nucl Med 2004;45:1931\u20138.","journal-title":"J Nucl Med"},{"key":"1496_CR46","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.2967\/jnumed.108.052639","volume":"49","author":"Y Yamamoto","year":"2008","unstructured":"Yamamoto Y, Nishiyama Y, Kameyama R, Okano K, Kashiwagi H, Deguchi A, et al. Detection of hepatocellular carcinoma using 11C-choline PET: comparison with 18F-FDG PET. J Nucl Med 2008;49:1245\u20138.","journal-title":"J Nucl Med"},{"key":"1496_CR47","first-page":"144","volume":"53","author":"N Salem","year":"2009","unstructured":"Salem N, Kuang Y, Wang F, Maclennan GT, Lee Z. PET imaging of hepatocellular carcinoma with 2-deoxy-2[18F]fluoro-D-glucose, 6-deoxy-6[18F] fluoro-D-glucose, [1-11C]-acetate and [N-methyl-11C]-choline. Q J Nucl Med Mol Imaging 2009;53:144\u201356.","journal-title":"Q J Nucl Med Mol Imaging"},{"key":"1496_CR48","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1007\/s00259-006-0164-9","volume":"33","author":"JN Talbot","year":"2006","unstructured":"Talbot JN, Gutman F, Fartoux L, Grange JD, Ganne N, Kerrou K, et al. PET\/CT in patients with hepatocellular carcinoma using [(18)F]fluorocholine: preliminary comparison with [(18)F]FDG PET\/CT. Eur J Nucl Med Mol Imaging 2006;33:1285\u20139.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1496_CR49","first-page":"1064","volume":"31","author":"M Tian","year":"2004","unstructured":"Tian M, Zhang H, Oriuchi N, Higuchi T, Endo K. Comparison of 11C-choline PET and FDG PET for the differential diagnosis of malignant tumors. Eur J Nucl Med Mol Imaging 2004;31:1064\u201372.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1496_CR50","first-page":"1507","volume":"41","author":"T Hara","year":"2000","unstructured":"Hara T, Inagaki K, Kosaka N, Morita T. Sensitive detection of mediastinal lymph node metastasis of lung cancer with 11C-choline PET. J Nucl Med 2000;41:1507\u201313.","journal-title":"J Nucl Med"},{"key":"1496_CR51","first-page":"167","volume":"43","author":"RM Pieterman","year":"2002","unstructured":"Pieterman RM, Que TH, Elsinga PH, Pruim J, van Putten JW, Willemsen AT, et al. Comparison of (11)C-choline and (18)F-FDG PET in primary diagnosis and staging of patients with thoracic cancer. J Nucl Med 2002;43:167\u201372.","journal-title":"J Nucl Med"},{"key":"1496_CR52","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1097\/00006231-200304000-00004","volume":"24","author":"N Khan","year":"2003","unstructured":"Khan N, Oriuchi N, Zhang H, Higuchi T, Tian M, Inoue T, et al. A comparative study of 11C-choline PET and [18F]fluorodeoxyglucose PET in the evaluation of lung cancer. Nucl Med Commun 2003;24:359\u201366.","journal-title":"Nucl Med Commun"},{"key":"1496_CR53","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1007\/s002590100655","volume":"28","author":"PL Jager","year":"2001","unstructured":"Jager PL, Que TH, Vaalburg W, Pruim J, Elsinga P, Plukker JT. Carbon-11 choline or FDG-PET for staging of oesophageal cancer? Eur J Nucl Med 2001;28:1845\u20139.","journal-title":"Eur J Nucl Med"},{"key":"1496_CR54","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/BF02984484","volume":"18","author":"N Khan","year":"2004","unstructured":"Khan N, Oriuchi N, Ninomiya H, Higuchi T, Kamada H, Endo K. Positron emission tomographic imaging with 11C-choline in differential diagnosis of head and neck tumors: comparison with 18F-FDG PET. Ann Nucl Med 2004;18:409\u201317.","journal-title":"Ann Nucl Med"},{"key":"1496_CR55","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/BF02985611","volume":"18","author":"H Ninomiya","year":"2004","unstructured":"Ninomiya H, Oriuchi N, Kahn N, Higuchi T, Endo K, Takahashi K, et al. Diagnosis of tumor in the nasal cavity and paranasal sinuses with [11C]choline PET: comparative study with 2-[18F]fluoro-2-deoxy-D-glucose (FDG) PET. Ann Nucl Med 2004;18:29\u201334.","journal-title":"Ann Nucl Med"},{"key":"1496_CR56","first-page":"1051","volume":"44","author":"T Torizuka","year":"2003","unstructured":"Torizuka T, Kanno T, Futatsubashi M, Okada H, Yoshikawa E, Nakamura F, et al. Imaging of gynecologic tumors: comparison of (11)C-choline PET with (18)F-FDG PET. J Nucl Med 2003;44:1051\u20136.","journal-title":"J Nucl Med"}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-010-1496-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00259-010-1496-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-010-1496-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,24]],"date-time":"2019-05-24T16:05:06Z","timestamp":1558713906000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00259-010-1496-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,6,11]]},"references-count":56,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2010,11]]}},"alternative-id":["1496"],"URL":"https:\/\/doi.org\/10.1007\/s00259-010-1496-z","relation":{},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"value":"1619-7070","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,6,11]]}}}